WeVote
Log In

Bill

Bill

SB 31

Use of Prescription Product with Controlled Substance

2026 Regular Session

Colorado SB 31 regulates prescription products with controlled substances through amended requirements that passed Senate second reading, balancing medication access with misuse prevention.

Governor Signed
#crimes #corrections #&enforcement
0
WeVote Research Nonpartisan
Bill Summary · SB 31

Legislative bill overview

SB 31 modifies Colorado law regarding prescription products containing controlled substances. The bill has advanced through committee with amendments and passed second reading in the Senate, though the specific provisions are not detailed in the action history provided. The bill appears to address regulatory or usage standards for such medications.

Why is this important

Prescription medications containing controlled substances (like opioids, benzodiazepines, and stimulants) affect millions of patients managing pain, anxiety, and other conditions. Changes to how these products are prescribed, dispensed, or used can impact patient access to treatment, public health outcomes, and efforts to combat substance misuse and addiction.

Potential points of contention

  • Patient access vs. abuse prevention: Stricter controls may reduce medication availability for legitimate medical needs while attempting to limit misuse
  • Healthcare provider autonomy: Regulations could limit prescriber discretion in clinical decision-making or increase administrative burdens
  • Implementation costs: Pharmacies and healthcare systems may face expenses adapting to new requirements or tracking mechanisms

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.